New US tax evasion rules scupper Pfizer-Allergan deal

US drug maker Pfizer has agreed to terminate its $US160 billion ($A212.30 billion) agreement to acquire Botox maker Allergan, in a major victory to US President Barack Obama's drive to stop tax-dodging corporate mergers.